These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8533776)

  • 1. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.
    Ford D; Easton DF; Peto J
    Am J Hum Genet; 1995 Dec; 57(6):1457-62. PubMed ID: 8533776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA
    Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
    Easton DF; Ford D; Bishop DT
    Am J Hum Genet; 1995 Jan; 56(1):265-71. PubMed ID: 7825587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D
    Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
    Moslehi R; Chu W; Karlan B; Fishman D; Risch H; Fields A; Smotkin D; Ben-David Y; Rosenblatt J; Russo D; Schwartz P; Tung N; Warner E; Rosen B; Friedman J; Brunet JS; Narod SA
    Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan.
    Liede A; Malik IA; Aziz Z; Rios Pd Pde L; Kwan E; Narod SA
    Am J Hum Genet; 2002 Sep; 71(3):595-606. PubMed ID: 12181777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
    Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
    Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic attributable risk of breast and ovarian cancer.
    Claus EB; Schildkraut JM; Thompson WD; Risch NJ
    Cancer; 1996 Jun; 77(11):2318-24. PubMed ID: 8635102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.
    Sarantaus L; Auranen A; Nevanlinna H
    Int J Oncol; 2001 Apr; 18(4):831-5. PubMed ID: 11251181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer.
    Whittemore AS; Gong G; Itnyre J
    Am J Hum Genet; 1997 Mar; 60(3):496-504. PubMed ID: 9042908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
    Narod SA; Ford D; Devilee P; Barkardottir RB; Lynch HT; Smith SA; Ponder BA; Weber BL; Garber JE; Birch JM
    Am J Hum Genet; 1995 Jan; 56(1):254-64. PubMed ID: 7825586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
    Van Der Looij M; Szabo C; Besznyak I; Liszka G; Csokay B; Pulay T; Toth J; Devilee P; King MC; Olah E
    Int J Cancer; 2000 Jun; 86(5):737-40. PubMed ID: 10797299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families.
    Papp J; Raicevic L; Milasin J; Dimitrijevic B; Radulovic S; Olah E
    Oncol Rep; 1999; 6(6):1435-8. PubMed ID: 10523726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.
    Simard J; Tonin P; Durocher F; Morgan K; Rommens J; Gingras S; Samson C; Leblanc JF; Bélanger C; Dion F
    Nat Genet; 1994 Dec; 8(4):392-8. PubMed ID: 7894492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.
    Peelen T; Cornelis RS; van Vliet M; Petrij-Bosch A; Cleton-Jansen AM; Meijers-Heijboer H; Klijn JG; Vasen HF; Cornelisse CJ; Devilee P
    Eur J Hum Genet; 1996; 4(4):225-30. PubMed ID: 8875189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary and familial ovarian cancer in southern Ontario.
    Narod SA; Madlensky L; Bradley L; Cole D; Tonin P; Rosen B; Risch HA
    Cancer; 1994 Oct; 74(8):2341-6. PubMed ID: 7922985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
    Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
    Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of breast and ovarian cancer.
    Ford D; Easton DF
    Br J Cancer; 1995 Oct; 72(4):805-12. PubMed ID: 7547224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
    J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
    Johannsson O; Ostermeyer EA; Håkansson S; Friedman LS; Johansson U; Sellberg G; Brøndum-Nielsen K; Sele V; Olsson H; King MC; Borg A
    Am J Hum Genet; 1996 Mar; 58(3):441-50. PubMed ID: 8644702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.